We are pleased to announce that our CEO, Nobuyuki Arakawa, will be speaking at the "TECHNIUM Global Conference 2025" on Thursday, May 8, 2025.
"The TECHNIUM Global Conference" is one of Japan’s largest deep tech events, bringing together approximately 2,000 participants—including researchers, startups, business leaders, corporates, government agencies, universities, and investors—from both Japan and abroad. The conference aims to foster an ecosystem that accelerates the creation and growth of globally competitive deep tech startups, connecting academia, industry, and government to drive innovation on the world stage.
Event Overview
Date: May 7 (Wed) – 8 (Thu), 2025
Venue: Imperial Hotel Tokyo
Organizer: TECHNIUM Global Conference Executive Committee
Co-organizers: Beyond Next Ventures Inc. / Hakuhodo Inc. / CoA Nexus Inc. / Corundum Co., Ltd.
Featured Session with Our CEO, Nobuyuki Arakawa
Date & Time: May 8 (Thu), 2025, 11:55–12:30
Room: Room B
Session: B-7 "Cell and Gene Therapy: Management Strategies and Future Outlook"
Powered by Osaka University Venture Capital
Moderator:Hiroki Sato (Osaka University Venture Capital Co., Ltd.)
Speakers:Nobuyuki Arakawa (President & CEO, Celaid Therapeutics Inc.)
Issei Omori (President & CEO, Revascular Bio Inc.)
Join us at the TECHNIUM Global Conference 2025, where leading innovators and industry experts gather to discuss the future of deep tech and business strategy in the field of cell and gene therapy.